Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03945188 · COMPLETED
Trial details
- NCT number
- NCT03945188
- Sponsor
- Arena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2022-02-08
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.